Creative Biolabs, a pioneer in advanced 3D biology solutions, has announced the integration of its comprehensive ocular toxicity and irritation evaluation suite.
SHIRLEY, NY, April 16, 2026 /24-7PressRelease/ — By combining reconstructed human corneal epithelium (RhCE) models with sophisticated retinal organoid platforms, the company now provides a seamless “Front-to-Back” ocular safety assessment pathway for pharmaceutical and cosmetic developers.
Bridging the Gap Between Surface Irritation and Deep Tissue Toxicity
The evaluation of ocular safety traditionally faced a fragmentation between surface-level irritation tests and deep-tissue toxicity assessments. Creative Biolabs addresses this by leveraging its specialized models to simulate the physiological structure of the human eye’s outermost layer. These models allow researchers to predict eye irritation levels with high sensitivity, adhering to international safety standards.
However, the industry’s focus is shifting toward the long-term effects of drugs on the posterior segment of the eye. To meet this demand, Creative Biolabs has introduced specialized services for ocular toxicity evaluation using human RPE cells. These models are critical for identifying drug-induced retinopathy, a common side effect in systemic drug development that often remains undetected in traditional 2D cell cultures.
Expert Insight on 3D Ocular Modeling
“The complexity of the human eye requires more than a single-cell layer approach,” says a senior scientist at Creative Biolabs’ 3D Biology Department. “By utilizing retinal organoids that mirror the stratified architecture of the actual human retina, we can observe real-time physiological responses to xenobiotics.”
Industry feedback reinforces this technical superiority. A lead researcher from a top-tier biotech firm recently noted: “The 3D RhCE models from Creative Biolabs provided us with highly reproducible data that closely correlated with our subsequent clinical observations, allowing us to bypass several rounds of preliminary screening.”
Technical Deep-Dive: Ocular Modeling FAQ
How do 3D RhCE models improve upon the Draize test? Unlike rabbit-based tests, reconstructed human corneal epithelium (RhCE) models utilize human cells to eliminate inter-species variability, providing precise “No Category” classification for regulatory compliance.
Why target the Retinal Pigment Epithelium (RPE)? The RPE is a critical blood-retinal barrier. They enable TEER measurements to detect pigment-mediated drug accumulation that 2D cultures often miss.
What is the benefit of the retinal organoid model? The retinal organoid model features stratified tissue layers, making it the gold standard for simulating chronic drug exposure and identifying delayed-onset retinal degeneration.
About
Creative Biolabs is a global leader in 3D biology, offering an extensive catalog of immortalized primary cells and specialized products for 3D culture. With a focus on ethical science and high-fidelity modeling, the company supports the global research community in transitioning toward more predictive, human-relevant in vitro assays.
—
For the original version of this press release, please visit 24-7PressRelease.com here
Legal Disclaimer:
The content on this page is syndicated from independent third-party providers. Kyrion Media makes no warranties or representations regarding the accuracy, completeness, legality, or reliability of the information, including text, images, videos, or licenses. If you are affiliated with this content or have any complaints, copyright concerns, or requests for removal, please contact us at retract@kyrionmedia.com with the specific URL of the content in question. We will review and address valid requests promptly.
